| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4240696 | Journal of Vascular and Interventional Radiology | 2007 | 8 Pages |
Abstract
Patients with HCC can tolerate high cumulative radiation doses with 90Y therapy. Compared with patients with Okuda stage II disease, patients with Okuda stage I disease tolerate a higher cumulative radiation dose without liver toxicity, but liver toxicities increase with increasing cumulative radiation doses.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Joseph Y. BS, Thomas K. MD, Bassel MD, Vanessa L. MS, Laura MD, Mary F. MD, Andrew C. PhD, Robert K. MD, Kent T. MD, Robert J. MD, Reed A. MD, MS, Riad MD, MBA,